Rock Creek Pharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.77 |
Market Cap |
$102.27 K |
Shares Outstanding |
170.45 M |
Public Float |
- |
Address |
2040 Whitfield Avenue Sarasota Florida 34243 United States |
Employees | - |
Website | - |
Updated | 07/08/2019 |
Rock Creek Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for chronic inflammatory disease, neurologic disorders, and behavioral health utilizing its proprietary compounds. It focuses on pharmaceutical development activities centered primarily on anatabine citrate as a lead drug candidate. The company was founded by Jonnie R. |